Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 2.160
+0.054 (2.56%)
Jun 12, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 537 million as of June 12, 2026. Its market cap has increased by 42.11% in one year.
Market Cap
537.00M
Enterprise Value
278.97M
Revenue
317.21M
Ranking
n/a
PE Ratio
3.38
Stock Price
2.16
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 537.00M, an increase of 345.45%. That is a compound annual growth rate of 14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 537.00M | -48.39% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 808.29M |
| SynAct Pharma AB | 771.60M |
| FluoGuide | 727.54M |
| Oncopeptides AB | 699.66M |
| Xspray Pharma AB | 687.54M |
| Corline Biomedical AB | 473.01M |
| Intervacc AB | 456.69M |
| AlzeCure Pharma AB | 455.06M |